Adenocarcinoma-associated antigen: Enhancement of tumor growth with serum from animals bearing adenocarcinoma
โ Scribed by Anwar A. Hakim
- Book ID
- 102924920
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 803 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Why do tumors continue to grow in the presence of cellโmediated immune reactions? When inoculated subcutaneously, 10^5^ viable spontaneous mammary adenocarcinoma cells produced solid tumors that progressively proliferated and eventually kilted all the recipient mice. During the first 10 days after inoculation, the mice developed antibody titers, and the serum acquired toxic activity against the tumor cells. As the tumor gained in size these two activities ceased. Serum of normal mice had no effect on the tumor; the serum of mice immunized with an adenocarcinomaโassociated antigen (a glycoprotein) inhibited growth, but that of mice with progressive tumors enhanced proliferation of the tumors.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. The presence of epidermal growth factor receptor (EGFR) gene mutations is a good indicator of the clinical efficacy of gefitinib in patients with nonsmall cell lung cancer. It was recently reported that the serum carcinoembryonic antigen (CEA) level could be a predictive
## Abstract An immunopotentiating factor associated with spleen cells of C57BL/6J mice bearing the 3LL tumor is described. Supernatants of cultured spleen cells from tumorโbearing mice (TBM) augmented the generation of both 19S and 7S antibodyโproducing cells, when injected with sheep erythrocytes